Report Thumbnail
Product Code QY09126134874RQ
Published Date 2024/5/1
English186 PagesGlobal

Global Animal IVD Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY09126134874RQ◆The May 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/5/1
English 186 PagesGlobal

Global Animal IVD Market Insights, Forecast to 2030Pharmaceutical_LifeSciense Market



Abstract


Summary

Animal in vitro diagnostics is widely regarded as the most effective method for identifying and characterizing various chronic diseases in animals. Several diagnostic methods are used to detect diseases, including molecular diagnostic, immunodiagnostic, clinical biochemistry, urinalysis, and others.
The global Animal IVD market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Animal IVD is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Animal IVD is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Animal IVD is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Animal IVD include Heska, Zoetis, Antech(Mars), Eurofins Ingenasa, IDEXX, Bio-Rad, Thermo Fisher Scientific, Randox, Idvet, Edan Instruments, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Animal IVD market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Animal IVD, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Animal IVD, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal IVD revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Animal IVD market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Animal IVD revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Heska, Zoetis, Antech(Mars), Eurofins Ingenasa, IDEXX, Bio-Rad, Thermo Fisher Scientific, Randox, Idvet, Edan Instruments, etc.
Market Segmentation
By Company
Heska
Zoetis
Antech(Mars)
Eurofins Ingenasa
IDEXX
Bio-Rad
Thermo Fisher Scientific
Randox
Idvet
Edan Instruments
Micropointbio
Mnchip
Seamaty
Digifluidic
Mindrayanimal
Wondfo Biotech
Dymind
Shenzhen Pukang Electronic Co., Ltd.
Genrui-bio
Tecom-cn
USTAR
Dawnsailbio
Quicking
Coyotebio
Anheal
Shenzhen Gangzhu Medical Technology Co., Ltd.
Sansure Biotech
Dian Diagnostics
Segment by Type
Immunodiagnosis
Clinical Biochemistry and Molecular Diagnosis
Hematology
Other
Segment by Application
Pet Hospital
Animal Husbandry and Veterinary System
Zoo
Research Institute Animal Experiment Center
Animal and Plant Quarantine Department
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Animal IVD in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal IVD companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal IVD revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

  • 1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Animal IVD Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
      • 1.2.2 Immunodiagnosis
      • 1.2.3 Clinical Biochemistry and Molecular Diagnosis
      • 1.2.4 Hematology
      • 1.2.5 Other
    • 1.3 Market by Application
      • 1.3.1 Global Animal IVD Market Share by Application: 2019 VS 2023 VS 2030
      • 1.3.2 Pet Hospital
      • 1.3.3 Animal Husbandry and Veterinary System
      • 1.3.4 Zoo
      • 1.3.5 Research Institute Animal Experiment Center
      • 1.3.6 Animal and Plant Quarantine Department
      • 1.3.7 Others
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Animal IVD Market Perspective (2019-2030)
    • 2.2 Global Animal IVD Growth Trends by Region
      • 2.2.1 Global Animal IVD Market Size by Region: 2019 VS 2023 VS 2030
      • 2.2.2 Animal IVD Historic Market Size by Region (2019-2024)
      • 2.2.3 Animal IVD Forecasted Market Size by Region (2025-2030)
    • 2.3 Animal IVD Market Dynamics
      • 2.3.1 Animal IVD Industry Trends
      • 2.3.2 Animal IVD Market Drivers
      • 2.3.3 Animal IVD Market Challenges
      • 2.3.4 Animal IVD Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Revenue Animal IVD by Players
      • 3.1.1 Global Animal IVD Revenue by Players (2019-2024)
      • 3.1.2 Global Animal IVD Revenue Market Share by Players (2019-2024)
    • 3.2 Global Animal IVD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Global Key Players of Animal IVD, Ranking by Revenue, 2022 VS 2023 VS 2024
    • 3.4 Global Animal IVD Market Concentration Ratio
      • 3.4.1 Global Animal IVD Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Animal IVD Revenue in 2023
    • 3.5 Global Key Players of Animal IVD Head office and Area Served
    • 3.6 Global Key Players of Animal IVD, Product and Application
    • 3.7 Global Key Players of Animal IVD, Date of Enter into This Industry
    • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Animal IVD Breakdown Data by Type

    • 4.1 Global Animal IVD Historic Market Size by Type (2019-2024)
    • 4.2 Global Animal IVD Forecasted Market Size by Type (2025-2030)
  • 5 Animal IVD Breakdown Data by Application

    • 5.1 Global Animal IVD Historic Market Size by Application (2019-2024)
    • 5.2 Global Animal IVD Forecasted Market Size by Application (2025-2030)
  • 6 North America

    • 6.1 North America Animal IVD Market Size (2019-2030)
    • 6.2 North America Animal IVD Market Size by Type
      • 6.2.1 North America Animal IVD Market Size by Type (2019-2024)
      • 6.2.2 North America Animal IVD Market Size by Type (2025-2030)
      • 6.2.3 North America Animal IVD Market Share by Type (2019-2030)
    • 6.3 North America Animal IVD Market Size by Application
      • 6.3.1 North America Animal IVD Market Size by Application (2019-2024)
      • 6.3.2 North America Animal IVD Market Size by Application (2025-2030)
      • 6.3.3 North America Animal IVD Market Share by Application (2019-2030)
    • 6.4 North America Animal IVD Market Size by Country
      • 6.4.1 North America Animal IVD Market Size by Country: 2019 VS 2023 VS 2030
      • 6.4.2 North America Animal IVD Market Size by Country (2019-2024)
      • 6.4.3 North America Animal IVD Market Share by Country (2025-2030)
      • 6.4.4 United States
      • 6.4.5 Canada
  • 7 Europe

    • 7.1 Europe Animal IVD Market Size (2019-2030)
    • 7.2 Europe Animal IVD Market Size by Type
      • 7.2.1 Europe Animal IVD Market Size by Type (2019-2024)
      • 7.2.2 Europe Animal IVD Market Size by Type (2025-2030)
      • 7.2.3 Europe Animal IVD Market Share by Type (2019-2030)
    • 7.3 Europe Animal IVD Market Size by Application
      • 7.3.1 Europe Animal IVD Market Size by Application (2019-2024)
      • 7.3.2 Europe Animal IVD Market Size by Application (2025-2030)
      • 7.3.3 Europe Animal IVD Market Share by Application (2019-2030)
    • 7.4 Europe Animal IVD Market Size by Country
      • 7.4.1 Europe Animal IVD Market Size by Country: 2019 VS 2023 VS 2030
      • 7.4.2 Europe Animal IVD Market Size by Country (2019-2024)
      • 7.4.3 Europe Animal IVD Market Size by Country (2025-2030)
      • 7.4.4 Germany
      • 7.4.5 France
      • 7.4.6 U.K.
      • 7.4.7 Italy
      • 7.4.8 Russia
      • 7.4.9 Nordic Countries
  • 8 China

    • 8.1 China Animal IVD Market Size (2019-2030)
    • 8.2 China Animal IVD Market Size by Type
      • 8.2.1 China Animal IVD Market Size by Type (2019-2024)
      • 8.2.2 China Animal IVD Market Size by Type (2025-2030)
      • 8.2.3 China Animal IVD Market Share by Type (2019-2030)
    • 8.3 China Animal IVD Market Size by Application
      • 8.3.1 China Animal IVD Market Size by Application (2019-2024)
      • 8.3.2 China Animal IVD Market Size by Application (2025-2030)
      • 8.3.3 China Animal IVD Market Share by Application (2019-2030)
  • 9 Asia (excluding China)

    • 9.1 Asia Animal IVD Market Size (2019-2030)
    • 9.2 Asia Animal IVD Market Size by Type
      • 9.2.1 Asia Animal IVD Market Size by Type (2019-2024)
      • 9.2.2 Asia Animal IVD Market Size by Type (2025-2030)
      • 9.2.3 Asia Animal IVD Market Share by Type (2019-2030)
    • 9.3 Asia Animal IVD Market Size by Application
      • 9.3.1 Asia Animal IVD Market Size by Application (2019-2024)
      • 9.3.2 Asia Animal IVD Market Size by Application (2025-2030)
      • 9.3.3 Asia Animal IVD Market Share by Application (2019-2030)
    • 9.4 Asia Animal IVD Market Size by Region
      • 9.4.1 Asia Animal IVD Market Size by Region: 2019 VS 2023 VS 2030
      • 9.4.2 Asia Animal IVD Market Size by Region (2019-2024)
      • 9.4.3 Asia Animal IVD Market Size by Region (2025-2030)
      • 9.4.4 Japan
      • 9.4.5 South Korea
      • 9.4.6 China Taiwan
      • 9.4.7 Southeast Asia
      • 9.4.8 India
      • 9.4.9 Australia
  • 10 Middle East, Africa, and Latin America

    • 10.1 Middle East, Africa, and Latin America Animal IVD Market Size (2019-2030)
    • 10.2 Middle East, Africa, and Latin America Animal IVD Market Size by Type
      • 10.2.1 Middle East, Africa, and Latin America Animal IVD Market Size by Type (2019-2024)
      • 10.2.2 Middle East, Africa, and Latin America Animal IVD Market Size by Type (2025-2030)
      • 10.2.3 Middle East, Africa, and Latin America Animal IVD Market Share by Type (2019-2030)
    • 10.3 Middle East, Africa, and Latin America Animal IVD Market Size by Application
      • 10.3.1 Middle East, Africa, and Latin America Animal IVD Market Size by Application (2019-2024)
      • 10.3.2 Middle East, Africa, and Latin America Animal IVD Market Size by Application (2025-2030)
      • 10.3.3 Middle East, Africa, and Latin America Animal IVD Market Share by Application (2019-2030)
    • 10.4 Middle East, Africa, and Latin America Animal IVD Market Size by Country
      • 10.4.1 Middle East, Africa, and Latin America Animal IVD Market Size by Country: 2019 VS 2023 VS 2030
      • 10.4.2 Middle East, Africa, and Latin America Animal IVD Market Size by Country (2019-2024)
      • 10.4.3 Middle East, Africa, and Latin America Animal IVD Market Size by Country (2025-2030)
      • 10.4.4 Brazil
      • 10.4.5 Mexico
      • 10.4.6 Turkey
      • 10.4.7 Saudi Arabia
      • 10.4.8 Israel
      • 10.4.9 GCC Countries
  • 11 Key Players Profiles

    • 11.1 Heska
      • 11.1.1 Heska Company Details
      • 11.1.2 Heska Business Overview
      • 11.1.3 Heska Animal IVD Introduction
      • 11.1.4 Heska Revenue in Animal IVD Business (2019-2024)
      • 11.1.5 Heska Recent Development
    • 11.2 Zoetis
      • 11.2.1 Zoetis Company Details
      • 11.2.2 Zoetis Business Overview
      • 11.2.3 Zoetis Animal IVD Introduction
      • 11.2.4 Zoetis Revenue in Animal IVD Business (2019-2024)
      • 11.2.5 Zoetis Recent Development
    • 11.3 Antech(Mars)
      • 11.3.1 Antech(Mars) Company Details
      • 11.3.2 Antech(Mars) Business Overview
      • 11.3.3 Antech(Mars) Animal IVD Introduction
      • 11.3.4 Antech(Mars) Revenue in Animal IVD Business (2019-2024)
      • 11.3.5 Antech(Mars) Recent Development
    • 11.4 Eurofins Ingenasa
      • 11.4.1 Eurofins Ingenasa Company Details
      • 11.4.2 Eurofins Ingenasa Business Overview
      • 11.4.3 Eurofins Ingenasa Animal IVD Introduction
      • 11.4.4 Eurofins Ingenasa Revenue in Animal IVD Business (2019-2024)
      • 11.4.5 Eurofins Ingenasa Recent Development
    • 11.5 IDEXX
      • 11.5.1 IDEXX Company Details
      • 11.5.2 IDEXX Business Overview
      • 11.5.3 IDEXX Animal IVD Introduction
      • 11.5.4 IDEXX Revenue in Animal IVD Business (2019-2024)
      • 11.5.5 IDEXX Recent Development
    • 11.6 Bio-Rad
      • 11.6.1 Bio-Rad Company Details
      • 11.6.2 Bio-Rad Business Overview
      • 11.6.3 Bio-Rad Animal IVD Introduction
      • 11.6.4 Bio-Rad Revenue in Animal IVD Business (2019-2024)
      • 11.6.5 Bio-Rad Recent Development
    • 11.7 Thermo Fisher Scientific
      • 11.7.1 Thermo Fisher Scientific Company Details
      • 11.7.2 Thermo Fisher Scientific Business Overview
      • 11.7.3 Thermo Fisher Scientific Animal IVD Introduction
      • 11.7.4 Thermo Fisher Scientific Revenue in Animal IVD Business (2019-2024)
      • 11.7.5 Thermo Fisher Scientific Recent Development
    • 11.8 Randox
      • 11.8.1 Randox Company Details
      • 11.8.2 Randox Business Overview
      • 11.8.3 Randox Animal IVD Introduction
      • 11.8.4 Randox Revenue in Animal IVD Business (2019-2024)
      • 11.8.5 Randox Recent Development
    • 11.9 Idvet
      • 11.9.1 Idvet Company Details
      • 11.9.2 Idvet Business Overview
      • 11.9.3 Idvet Animal IVD Introduction
      • 11.9.4 Idvet Revenue in Animal IVD Business (2019-2024)
      • 11.9.5 Idvet Recent Development
    • 11.10 Edan Instruments
      • 11.10.1 Edan Instruments Company Details
      • 11.10.2 Edan Instruments Business Overview
      • 11.10.3 Edan Instruments Animal IVD Introduction
      • 11.10.4 Edan Instruments Revenue in Animal IVD Business (2019-2024)
      • 11.10.5 Edan Instruments Recent Development
    • 11.11 Micropointbio
      • 11.11.1 Micropointbio Company Details
      • 11.11.2 Micropointbio Business Overview
      • 11.11.3 Micropointbio Animal IVD Introduction
      • 11.11.4 Micropointbio Revenue in Animal IVD Business (2019-2024)
      • 11.11.5 Micropointbio Recent Development
    • 11.12 Mnchip
      • 11.12.1 Mnchip Company Details
      • 11.12.2 Mnchip Business Overview
      • 11.12.3 Mnchip Animal IVD Introduction
      • 11.12.4 Mnchip Revenue in Animal IVD Business (2019-2024)
      • 11.12.5 Mnchip Recent Development
    • 11.13 Seamaty
      • 11.13.1 Seamaty Company Details
      • 11.13.2 Seamaty Business Overview
      • 11.13.3 Seamaty Animal IVD Introduction
      • 11.13.4 Seamaty Revenue in Animal IVD Business (2019-2024)
      • 11.13.5 Seamaty Recent Development
    • 11.14 Digifluidic
      • 11.14.1 Digifluidic Company Details
      • 11.14.2 Digifluidic Business Overview
      • 11.14.3 Digifluidic Animal IVD Introduction
      • 11.14.4 Digifluidic Revenue in Animal IVD Business (2019-2024)
      • 11.14.5 Digifluidic Recent Development
    • 11.15 Mindrayanimal
      • 11.15.1 Mindrayanimal Company Details
      • 11.15.2 Mindrayanimal Business Overview
      • 11.15.3 Mindrayanimal Animal IVD Introduction
      • 11.15.4 Mindrayanimal Revenue in Animal IVD Business (2019-2024)
      • 11.15.5 Mindrayanimal Recent Development
    • 11.16 Wondfo Biotech
      • 11.16.1 Wondfo Biotech Company Details
      • 11.16.2 Wondfo Biotech Business Overview
      • 11.16.3 Wondfo Biotech Animal IVD Introduction
      • 11.16.4 Wondfo Biotech Revenue in Animal IVD Business (2019-2024)
      • 11.16.5 Wondfo Biotech Recent Development
    • 11.17 Dymind
      • 11.17.1 Dymind Company Details
      • 11.17.2 Dymind Business Overview
      • 11.17.3 Dymind Animal IVD Introduction
      • 11.17.4 Dymind Revenue in Animal IVD Business (2019-2024)
      • 11.17.5 Dymind Recent Development
    • 11.18 Shenzhen Pukang Electronic Co., Ltd.
      • 11.18.1 Shenzhen Pukang Electronic Co., Ltd. Company Details
      • 11.18.2 Shenzhen Pukang Electronic Co., Ltd. Business Overview
      • 11.18.3 Shenzhen Pukang Electronic Co., Ltd. Animal IVD Introduction
      • 11.18.4 Shenzhen Pukang Electronic Co., Ltd. Revenue in Animal IVD Business (2019-2024)
      • 11.18.5 Shenzhen Pukang Electronic Co., Ltd. Recent Development
    • 11.19 Genrui-bio
      • 11.19.1 Genrui-bio Company Details
      • 11.19.2 Genrui-bio Business Overview
      • 11.19.3 Genrui-bio Animal IVD Introduction
      • 11.19.4 Genrui-bio Revenue in Animal IVD Business (2019-2024)
      • 11.19.5 Genrui-bio Recent Development
    • 11.20 Tecom-cn
      • 11.20.1 Tecom-cn Company Details
      • 11.20.2 Tecom-cn Business Overview
      • 11.20.3 Tecom-cn Animal IVD Introduction
      • 11.20.4 Tecom-cn Revenue in Animal IVD Business (2019-2024)
      • 11.20.5 Tecom-cn Recent Development
    • 11.21 USTAR
      • 11.21.1 USTAR Company Details
      • 11.21.2 USTAR Business Overview
      • 11.21.3 USTAR Animal IVD Introduction
      • 11.21.4 USTAR Revenue in Animal IVD Business (2019-2024)
      • 11.21.5 USTAR Recent Development
    • 11.22 Dawnsailbio
      • 11.22.1 Dawnsailbio Company Details
      • 11.22.2 Dawnsailbio Business Overview
      • 11.22.3 Dawnsailbio Animal IVD Introduction
      • 11.22.4 Dawnsailbio Revenue in Animal IVD Business (2019-2024)
      • 11.22.5 Dawnsailbio Recent Development
    • 11.23 Quicking
      • 11.23.1 Quicking Company Details
      • 11.23.2 Quicking Business Overview
      • 11.23.3 Quicking Animal IVD Introduction
      • 11.23.4 Quicking Revenue in Animal IVD Business (2019-2024)
      • 11.23.5 Quicking Recent Development
    • 11.24 Coyotebio
      • 11.24.1 Coyotebio Company Details
      • 11.24.2 Coyotebio Business Overview
      • 11.24.3 Coyotebio Animal IVD Introduction
      • 11.24.4 Coyotebio Revenue in Animal IVD Business (2019-2024)
      • 11.24.5 Coyotebio Recent Development
    • 11.25 Anheal
      • 11.25.1 Anheal Company Details
      • 11.25.2 Anheal Business Overview
      • 11.25.3 Anheal Animal IVD Introduction
      • 11.25.4 Anheal Revenue in Animal IVD Business (2019-2024)
      • 11.25.5 Anheal Recent Development
    • 11.26 Shenzhen Gangzhu Medical Technology Co., Ltd.
      • 11.26.1 Shenzhen Gangzhu Medical Technology Co., Ltd. Company Details
      • 11.26.2 Shenzhen Gangzhu Medical Technology Co., Ltd. Business Overview
      • 11.26.3 Shenzhen Gangzhu Medical Technology Co., Ltd. Animal IVD Introduction
      • 11.26.4 Shenzhen Gangzhu Medical Technology Co., Ltd. Revenue in Animal IVD Business (2019-2024)
      • 11.26.5 Shenzhen Gangzhu Medical Technology Co., Ltd. Recent Development
    • 11.27 Sansure Biotech
      • 11.27.1 Sansure Biotech Company Details
      • 11.27.2 Sansure Biotech Business Overview
      • 11.27.3 Sansure Biotech Animal IVD Introduction
      • 11.27.4 Sansure Biotech Revenue in Animal IVD Business (2019-2024)
      • 11.27.5 Sansure Biotech Recent Development
    • 11.28 Dian Diagnostics
      • 11.28.1 Dian Diagnostics Company Details
      • 11.28.2 Dian Diagnostics Business Overview
      • 11.28.3 Dian Diagnostics Animal IVD Introduction
      • 11.28.4 Dian Diagnostics Revenue in Animal IVD Business (2019-2024)
      • 11.28.5 Dian Diagnostics Recent Development
  • 12 Analyst's Viewpoints/Conclusions

  • 13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
        • 13.1.1.1 Research Programs/Design
        • 13.1.1.2 Market Size Estimation
        • 13.1.1.3 Market Breakdown and Data Triangulation
      • 13.1.2 Data Source
        • 13.1.2.1 Secondary Sources
        • 13.1.2.2 Primary Sources
    • 13.2 Author Details
    • 13.3 Disclaimer
USD 4,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.